US stock · US markets · public data

RMD

Resmed Inc · Healthcare

Reference price$235.42Updated according to the public source
P/E22.57
P/B5.16
ROE24.27%
DY 12M1.02%
Net margin—
Net debt/equity—
Market capUS$ 33.1 B
Volume (shares)680,059
SectorHealthcare
Overview

About RMD

Demonstrações públicas consolidadas + SEC Company Facts

Resmed Inc (RMD) is a stock traded in US markets in the Healthcare sector. Revenue (FY2026): US$ 5.65 B. Net income (FY2026): US$ 1.52 B. Operating cash flow (FY2026): US$ 1.81 B.

Available statements: Income statement, Balance sheet, Cash flow. Most recent period in the first statement: FY2026.

Distributions

Dividends and distributions · last 12 records

public data
09/22
12/22
03/23
09/23
12/23
03/24
09/24
12/24
03/25
09/25
12/25
03/26
Income in shown records$6.15
DY 12M1.02%
Records shown12
Date / reported periodTypeValue per share/unit
Period ending 2026-03-31Dividendo declarado$0.60
Period ending 2025-12-31Dividendo declarado$0.60
Period ending 2025-09-30Dividendo declarado$0.60
Period ending 2025-03-31Dividendo declarado$0.53
Period ending 2024-12-31Dividendo declarado$0.53
Period ending 2024-09-30Dividendo declarado$0.53

SEC records describe reported fiscal periods, not ex-dividend or payment dates. Only separately reported quarters are shown; missing quarters do not mean zero dividends.

Reported dividends per share · FY2026: $2.40. This fiscal-year total is separate from the quarterly records and is not a trailing 12-month yield.

Financials

Income statement, balance sheet and cash flow

Available

Latest fiscal period: FY2026 (2025-07-01 – 2026-06-30).

Income statement

Account2023202420252026
Revenue$4,222,993,000.00$4,685,297,000.00$5,146,327,000.00$5,653,443,000.00
Gross Profit$2,355,662,000.00$2,655,303,000.00$3,054,970,000.00$3,451,739,000.00
Operating Income$1,131,871,000.00$1,319,893,000.00$1,685,363,000.00$1,886,715,000.00
Net Income$897,556,000.00$1,020,951,000.00$1,400,723,000.00$1,523,293,000.00
EPS Diluted$6.09 / share$6.92 / share$9.51 / share$10.43 / share

Balance sheet

Account2023202420252026
Total Assets$6,751,708,000.00$6,872,394,000.00$8,174,391,000.00$8,965,950,000.00
Total Liabilities$2,621,805,000.00$2,008,351,000.00$2,206,532,000.00$2,380,557,000.00
Total Equity$4,129,903,000.00$4,864,043,000.00$5,967,859,000.00$6,585,393,000.00
Long-term Debt$1,431,234,000.00$697,313,000.00$658,392,000.00$399,415,000.00
Current Debt$9,902,000.00$9,900,000.00$9,900,000.00$259,950,000.00
Shares Outstanding147,064,349 shares146,901,045 shares146,385,350 shares144,239,563 shares
Cash & Investments$227,891,000.00$238,361,000.00$1,209,450,000.00$1,469,234,000.00
Dívida Líquida$1,213,245,000.00$468,852,000.00-$541,158,000.00-$809,869,000.00

Cash flow

Account2023202420252026
Operating Cash Flow$693,299,000.00$1,401,260,000.00$1,751,588,000.00$1,805,829,000.00
Capital Expenditures$119,672,000.00$99,460,000.00$89,865,000.00$156,285,000.00
Dividends Paid$258,276,000.00$282,320,000.00$310,880,000.00$349,662,000.00
Free Cash Flow$573,627,000.00$1,301,800,000.00$1,661,723,000.00$1,649,544,000.00
FAQ

Frequently asked questions

What is the price of RMD?

The reference price available for RMD is $235.42.

What is the P/E of RMD?

The P/E ratio of RMD is 22.57. This compares price with reported earnings per share; a non-positive multiple is not a low positive earnings multiple.

What is the P/B of RMD?

The P/B of RMD is 5.16. This compares price with reported book value per share.

What is the ROE of RMD?

The ROE (Return on Equity) of RMD is 24.27%. This relates the reported net result to shareholders' equity.

What is the dividend yield of RMD?

The dividend yield of RMD is 1.02%. The provider may use annualized dividends; this is not a guaranteed return.

What is the market cap of RMD?

The market capitalization of RMD is US$ 33.1 B.

What sector is RMD in?

RMD operates in the Healthcare sector.

FundamentalRadar · educational information, not investment advice.